JNJ-77471056

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameJNJ-77471056
Drug Alias NameGluN2B-containing NMDA positive modulator (Janssen Pharmaceutica NV)JNJ-77471056
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor subunit epsilon 2 modulators
TargetsGlutamate [NMDA] receptor subunit epsilon 2
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumSpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Pharmaceutica NV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Pharmaceutica NVJanssen Cilag Sa
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A